A proteasome-dependent inhibition of SIRT-1 by the resveratrol analogue 4,4'-dihydroxy-<i>trans-</i>stilbene.

J Tradit Complement Med · 2024 · PMC11384077 · PMID 39262665

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp ≤ 0.01actually significant

22 In the time-response experiment, after 1 h of 30 μM DHS-treatment, BrdU incorporation was highly significant reduced (80%, p ≤ 0.01), and this strong inhibition was maintained until 24 h of treatment ( Fig. 2 D).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.